Cargando…

ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis

The endoplasmic reticulum (ER) is an important organelle that regulates several fundamental cellular processes, and ER dysfunction has implications for many intracellular events. The nucleotide-binding oligomerization domain-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome is an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xinnong, Guo, Xiaochen, Ge, Qihui, Zhao, Yixuan, Mu, Huaiyu, Zhang, Junping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800950/ https://www.ncbi.nlm.nih.gov/pubmed/31687078 http://dx.doi.org/10.1155/2019/3462530

Ejemplares similares

Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
por: Jin, Ying, et al.
Publicado: (2019)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

ER stress induces NLRP3 inflammasome activation and hepatocyte death
por: Lebeaupin, C, et al.
Publicado: (2015)

Pyroptosis in NLRP3 inflammasome-related atherosclerosis
por: Zeng, Xiang, et al.
Publicado: (2022)

NLRP3 inflammasome: a novel link between lipoproteins and atherosclerosis
por: Li, Wang Li, et al.
Publicado: (2016)

ER stress activates the NLRP3 inflammasome via an UPR-independent pathway
por: Menu, P, et al.
Publicado: (2012)

The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
por: Paramel Varghese, Geena, et al.
Publicado: (2016)

A novel mechanism for NLRP3 inflammasome activation
por: Zhang, Tan, et al.
Publicado: (2022)

Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation
por: de la Roche, Marianne, et al.
Publicado: (2018)

Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
por: Jiang, Chunteng, et al.
Publicado: (2021)

Effects and mechanisms of SGLT2 inhibitors on the NLRP3 inflammasome, with a focus on atherosclerosis
por: Yang, Liu, et al.
Publicado: (2022)

NFAT5 mediates hypertonic stress-induced atherosclerosis via activating NLRP3 inflammasome in endothelium
por: Ma, Pingping, et al.
Publicado: (2019)

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
por: Wan, Zhaofei, et al.
Publicado: (2019)

NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis
por: Liu, Yang, et al.
Publicado: (2020)

Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis
por: Wang, Yanan, et al.
Publicado: (2023)

Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
por: Tanase, Daniela Maria, et al.
Publicado: (2023)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice
por: Zhao, Jingfei, et al.
Publicado: (2020)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice
por: Wang, Renqing, et al.
Publicado: (2017)

Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
por: Menu, P, et al.
Publicado: (2011)

Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation
por: Gregersen, Ida, et al.
Publicado: (2017)

Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation
por: Wen, Jiexia, et al.
Publicado: (2020)

Oridonin supplementation attenuates atherosclerosis via NLRP-3 inflammasome pathway suppression
por: Sultan, Ahmed, et al.
Publicado: (2023)

Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes
por: Ding, Sujuan, et al.
Publicado: (2019)

Editorial: Novel perspectives on the NLRP3 inflammasome
por: Liang, Ying, et al.
Publicado: (2023)

Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition
por: Ma, Sai, et al.
Publicado: (2018)

Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction
por: Silvis, Max J. M., et al.
Publicado: (2020)

Biejiajian Pill Ameliorates Diabetes-Associated Atherosclerosis through Inhibition of the NLRP3 Inflammasome
por: Fu, Yu, et al.
Publicado: (2022)

STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection
por: Wang, Wenbiao, et al.
Publicado: (2020)

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
por: Kelley, Nathan, et al.
Publicado: (2019)

An update on the regulatory mechanisms of NLRP3 inflammasome activation
por: Paik, Seungwha, et al.
Publicado: (2021)

The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
por: Artlett, Carol M.
Publicado: (2022)

Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease
por: Zhang, Ge, et al.
Publicado: (2021)

NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis
por: Burger, Fabienne, et al.
Publicado: (2021)

Nur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome-Mediated Inflammation and Accelerates Atherosclerosis
por: Yuan, Ruosen, et al.
Publicado: (2022)

Neutrophil Extracellular Traps and NLRP3 Inflammasome: A Disturbing Duo in Atherosclerosis, Inflammation and Atherothrombosis
por: Singh, Puneetpal, et al.
Publicado: (2023)

Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
por: Lu, Zheng, et al.
Publicado: (2023)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k30f41t9mketo4fkk7gou8db1q